MATEO MEJIA SALDARRIAGA M.D
NPI 1417400540
Internal Medicine - Hematology & Oncology in New York, NY

Active since July 25, 2016PECOS EnrolledAccepts Medicare Assignment
425 E 61ST ST, NEW YORK, NY 10065(347) 764-0880 Get Directions Write a Review

NPPES record last updated: August 16, 2023. Verified against the NPPES registry weekly; last sync: July 26, 2026.

Record update history: Aug 16, 2023, Nov 25, 2019 (2 updates tracked since 2019).

About Mateo Mejia Saldarriaga M.d NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

MATEO MEJIA SALDARRIAGA M.D (NPI 1417400540) is an individual hematology & oncology provider in New York, New York, licensed in New York (301401) and active in the NPI registry since July 2016. He is enrolled in Medicare PECOS, is affiliated with New York-presbyterian Hospital, and is a graduate of Other (2014).

NPPES Registry Identity

NPI1417400540
Entity TypeIndividualMale
Primary Taxonomy207RH0003X
Provider Legal NameMATEO MEJIA SALDARRIAGACredential: M.D
Location Address425 E 61ST STNew York, NY 10065-8722
Mailing Address425 E 61st StNew York, NY 10065-8722 · (347) 764-0880
Sole ProprietorNo
Medical School CMSOtherGraduated 2014
Enumeration DateJuly 25, 2016
Last NPPES UpdateAugust 16, 20232 updates tracked since enumeration
NPPES CertifiedAugust 16, 2023
NPI 1417400540 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyInternal Medicine · Hematology & OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RH0003X
License Licensed in NY · 301401
Definition
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Also ListedInternal MedicineTaxonomy 207R00000X · License 301401 (NY)
425 E 61ST ST, New York, NY 10065

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Mateo Mejia Saldarriaga M.d is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9133583933
PECOS Enrollment IDI20230913000126
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 19

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, daratumumab, 10 mg and hyaluronidase-fihj J9144
Daratumumab and hyaluronidase-fihj is an injection administered to treat certain types of blood cancer. The medication works by targeting and killing specific cancer cells. It's often given under the skin to reduce side effects and improve patient comfort.
38,520 services33 patients
Injection, darbepoetin alfa, 1 microgram (non-esrd use) J0881
Darbepoetin alfa injection is a medication used to treat anemia (low red blood cell count) often caused by chronic kidney disease or chemotherapy. It works by stimulating your body to produce more red blood cells, helping to increase your energy and well-being.
7,050 services12 patients
Injection, bortezomib, 0.1 mg J9041
Bortezomib (Velcade) is a medication administered through an injection. It's used to treat multiple myeloma and mantle cell lymphoma, types of cancer. It works by blocking certain proteins in cancer cells, slowing their growth.
4,816 services22 patients
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg J1568
This procedure involves an intravenous injection of Octagam, a liquid immune globulin. It is a blood product that helps your body fight off infections. It's given through a vein (IV) and each dose contains 500 mg of the medication.
3,270 services20 patients
Insertion of needle into vein for collection of blood sample 36415
This procedure involves inserting a small needle into a vein, typically in your arm, to collect a blood sample. It's a quick and simple process to help diagnose or monitor health conditions. You may feel a small prick, but discomfort is minimal.
376 services145 patients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 99233
Follow-up hospital inpatient care per day typically involves a 35-minute check-up by your healthcare provider. This service includes monitoring your health progress, adjusting your treatment plan if needed, and answering any questions you may have about your condition or care.
338 services89 patients

Hospital Affiliations CMS Care Compare

Hospitals where this provider delivers care, identified from recent Medicare claims and place-of-service records.

New York-Presbyterian Hospital

Acute Care Hospitals · New York, NY
5/5 CMS rating
OwnershipVoluntary non-profit - Private
CMS Certification Number330101
Location525 East 68th StreetNew York, NY 10065 · New York County
Emergency services Birthing friendly

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 10065 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$198.19 typical visit price
range $65.69 – $198.19
Typical copayment $49.54 (range $16.42 – $49.54)
Most-billed visit code 99205
Established Patient
$114.88 typical visit price
range $21.20 – $160.66
Typical copayment $28.72 (range $5.30 – $40.16)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Internal Medicine
425 E 61ST ST
NEW YORK, NY 10065
Psychologist
425 E 61ST ST, PH FLOOR
NEW YORK, NY 10065
Nurse Practitioner (Acute Care)
425 E 61ST ST
NEW YORK, NY 10065
Nurse Practitioner (Adult Health)
425 E 61ST ST, 8TH FLOOR
NEW YORK, NY 10065
Nurse Practitioner (Adult Health)
425 E 61ST ST, 5TH FLOOR
NEW YORK, NY 10065
Internal Medicine (Pulmonary Disease)
425 E 61ST ST, 4TH FLOOR
NEW YORK, NY 10065
Radiology (Diagnostic Radiology)
425 E 61ST ST
NEW YORK, NY 10065
Nurse Practitioner (Family)
425 E 61ST ST, 5TH FLOOR
NEW YORK, NY 10065

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Mateo Mejia Saldarriaga's NPI number?

The NPI number for Mateo Mejia Saldarriaga is 1417400540. It was assigned to this individual provider in the NPPES registry on July 25, 2016.

Where is Mateo Mejia Saldarriaga located?

Mateo Mejia Saldarriaga practices at 425 E 61st St, New York, NY 10065. The listed phone number is (347) 764-0880.

What is Mateo Mejia Saldarriaga's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Hematology & Oncology, with taxonomy code 207RH0003X.

Is Mateo Mejia Saldarriaga enrolled in Medicare?

Yes. Mateo Mejia Saldarriaga is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

Is Mateo Mejia Saldarriaga affiliated with any hospitals?

According to CMS data, Mateo Mejia Saldarriaga is affiliated with New York-Presbyterian Hospital.

When was this NPI record last updated?

The NPPES record for Mateo Mejia Saldarriaga was last updated on August 16, 2023. NPI Profile syncs with the weekly NPPES data releases published by CMS.